{"status": "OK", "response": {"docs": [{"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": "Millions of Americans live with macular degeneration, a leading cause of vision loss among older people, and Stargardt's disease, a similar condition that arises in late childhood. Stephen Rose, chief research officer for the Foundation Fighting Blindness, recently joined the Consults blog to answer reader questions about these retinal degenerative diseases. Here, Dr. Rose responds to reader questions about potential treatments for macular degeneration and Stargardt's disease that are currently under investigation.", "headline": {"main": "Experimental Treatments for Macular Degeneration", "kicker": "Consults"}, "abstract": "Stephen Rose of the Foundation Fighting Blindness responds to reader questions about treatments now under investigation for macular degeneration and Stargardt's disease.", "print_page": null, "word_count": 1702, "_id": "4fd3a0ec8eb7c8105d8e6d74", "snippet": "Stephen Rose of the Foundation Fighting Blindness responds to reader questions about treatments now under investigation for macular degeneration and Stargardt's disease.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://consults.blogs.nytimes.com/2011/09/21/experimental-treatments-for-macular-degeneration/", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Computer Chips", "name": "subject", "rank": "4"}, {"value": "Clinical Trials", "name": "subject", "rank": "3"}, {"value": "Blindness", "name": "subject", "rank": "2"}, {"value": "Eyes and Eyesight", "name": "subject", "rank": "5"}, {"value": "News", "name": "type_of_material", "rank": "1"}, {"value": "Macular Degeneration", "name": "subject", "rank": "6"}, {"value": "Medicine and Health", "name": "subject", "rank": "7"}, {"value": "Research", "name": "subject", "rank": "8"}, {"value": "Stem Cells", "name": "subject", "rank": "9"}], "byline": {"organization": "THE NEW YORK TIMES", "original": "By THE NEW YORK TIMES", "person": []}, "document_type": "blogpost", "pub_date": "2011-09-21T16:04:54Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "The president\u2019s plan would increase payments for many beneficiaries, while some providers would receive less from the government.", "headline": {"seo": "Medicare and Medicaid Face $320 Billion in Cuts Over 10 Years", "main": "Obama Proposes $320 Billion in Medicare and Medicaid Cuts Over 10 Years", "print_headline": "Obama Proposes $320 Billion in Medicare and Medicaid Cuts Over 10 Years"}, "abstract": null, "print_page": "14", "word_count": "876", "_id": "540132da79881068a19481b6", "snippet": "The president\u2019s plan would increase payments for many beneficiaries, while some providers would receive less from the government.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2011/09/20/us/politics/medicare-and-medicaid-face-320-billion-in-cuts-over-10-years.html", "multimedia": [], "subsection_name": "Politics", "keywords": [{"value": "Obama, Barack", "is_major": "N", "rank": "1", "name": "persons"}, {"value": "Federal Budget (US)", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Medicare", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Medicaid", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Health Insurance and Managed Care", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "Reform and Reorganization", "is_major": "N", "rank": "7", "name": "subject"}, {"value": "United States Economy", "is_major": "N", "rank": "8", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robert", "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "2011-09-20T00:00:00Z", "section_name": "U.S."}], "meta": {"hits": 2, "offset": 0, "time": 69}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}